Endocrine therapy mainly includes selective estrogen receptor modulators (SERM), and aromatase inhibitors (AI), which can impede estrogen stimulation of cancer cells through competitive binding to ER or through inhibition of estrogen synthesis (67). The gene discussed is ESR1; the disease is cancer.